NDC 70436-196 – Diltiazem Hydrochloride
Diltiazem Hydrochloride 180 mg/1 · Tablet, Extended Release · Oral
Product NDC70436-196
Product details
- Brand name
- Diltiazem Hydrochloride
- Generic name
- Diltiazem Hydrochloride
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA216439
- Marketed since
- March 20, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Calcium Channel Blocker
Active ingredients
- Diltiazem Hydrochloride 180 mg/1
Uses, dosage, side effects and warnings for Diltiazem Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 70436-196-04 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-04) | Mar 20, 2023 |
| 70436-196-06 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-196-06) | Mar 20, 2023 |
Other Diltiazem Hydrochloride products
- 50090-0451 Diltiazem Hydrochloride 60 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7401 Diltiazem Hydrochloride 60 mg/1 · Tablet · A-S Medication Solutions
- 50090-5416 Diltiazem Hydrochloride 120 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 50090-5452 Diltiazem Hydrochloride 240 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 50090-7815 Diltiazem Hcl 240 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 50090-6328 Diltiazem Hydrochloride 120 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 50090-5466 Diltiazem Hydrochloride 180 mg/1 · Capsule, Extended Release · A-S Medication Solutions
- 16729-305 Diltiazem Hydrochloride 240 mg/1 · Capsule, Extended Release · Accord Healthcare, Inc.
- 16729-303 Diltiazem Hydrochloride 120 mg/1 · Capsule, Extended Release · Accord Healthcare, Inc.
- 16729-304 Diltiazem Hydrochloride 180 mg/1 · Capsule, Extended Release · Accord Healthcare, Inc.
- 0228-2918 Diltiazem Hydrochloride 360 mg/1 · Capsule, Extended Release · Actavis Pharma, Inc.
- 62332-725 Diltiazem Hydrochloride 120 mg/1 · Capsule, Extended Release · Alembic Pharmaceuticals Inc.